| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Nov-08 | | Total Revenue | 177,836 | 182,736 | 244,737 | 185,403 | | Cost of Revenue | 127,761 | 132,838 | 177,651 | 129,048 | | | Gross Profit | 50,075 | 49,898 | 67,086 | 56,355 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 18,449 | 18,785 | 27,790 | 17,945 | | Non Recurring |
-
|
-
| 14,608 |
-
| | Others | 11,949 | 12,250 | 16,188 | 12,167 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,677 | 18,863 | 8,500 | 26,243 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (37,375) |
-
|
-
| | Earnings Before Interest And Taxes | 19,677 | (18,512) | 8,500 | 26,243 | | Interest Expense | 4,142 | 4,060 | 6,757 | 5,096 | | Income Before Tax | 15,535 | (22,572) | 1,743 | 21,147 | | Income Tax Expense | 6,659 | (7,759) | 1,009 | 8,566 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,876 | (14,813) | 734 | 12,581 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,876 | (14,813) | 734 | 12,581 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,876 | ($14,813) | $734 | $12,581 |
|
0.26% Nasdaq 
Income Statement
